NVO logo

Novo Nordisk A/S (NVO) EBIT

Annual EBIT

$15.28 B
+$5.43 B+55.18%

31 December 2023

NVO EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly EBIT

$5.19 B
+$1.31 B+33.65%

30 September 2024

NVO Quarterly EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM EBIT

$17.70 B
+$773.47 M+4.57%

30 September 2024

NVO TTM EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NVO EBIT Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+55.2%+17.5%+37.6%
3 y3 years+86.3%+104.0%+90.4%
5 y5 years+102.2%+169.2%+135.8%

NVO EBIT High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+86.3%at high+355.9%at high+90.4%
5 y5 yearsat high+108.9%at high+355.9%at high+141.7%
alltimeall timeat high>+9999.0%at high+382.8%at high+2480.3%

Novo Nordisk A/S EBIT History

DateAnnualQuarterlyTTM
Sept 2024
-
$5.19 B(+33.6%)
$17.70 B(+4.6%)
June 2024
-
$3.88 B(-21.6%)
$16.93 B(+1.8%)
Mar 2024
-
$4.95 B(+34.4%)
$16.63 B(+7.9%)
Dec 2023
$15.28 B(+55.2%)
$3.68 B(-16.6%)
$15.41 B(+19.8%)
Sept 2023
-
$4.41 B(+23.1%)
$12.87 B(+12.9%)
June 2023
-
$3.59 B(-3.8%)
$11.40 B(+6.7%)
Mar 2023
-
$3.73 B(+227.7%)
$10.68 B(+8.2%)
Dec 2022
$9.84 B(+4.2%)
$1.14 B(-61.4%)
$9.87 B(-6.3%)
Sept 2022
-
$2.95 B(+2.6%)
$10.54 B(+4.0%)
June 2022
-
$2.87 B(-1.7%)
$10.14 B(+4.9%)
Mar 2022
-
$2.92 B(+61.9%)
$9.66 B(+2.2%)
Dec 2021
$9.45 B(+15.2%)
$1.80 B(-29.1%)
$9.45 B(+1.7%)
Sept 2021
-
$2.54 B(+6.2%)
$9.30 B(+5.7%)
June 2021
-
$2.40 B(-11.7%)
$8.79 B(+4.0%)
Mar 2021
-
$2.71 B(+64.5%)
$8.46 B(+3.7%)
Dec 2020
$8.20 B(+12.1%)
$1.65 B(-19.1%)
$8.15 B(+5.8%)
Sept 2020
-
$2.04 B(-1.0%)
$7.71 B(+1.5%)
June 2020
-
$2.06 B(-14.6%)
$7.60 B(+0.4%)
Mar 2020
-
$2.41 B(+100.2%)
$7.57 B(+3.3%)
Dec 2019
$7.31 B(-3.2%)
$1.20 B(-37.5%)
$7.33 B(-2.5%)
Sept 2019
-
$1.93 B(-4.9%)
$7.51 B(+1.1%)
June 2019
-
$2.03 B(-6.6%)
$7.42 B(-1.3%)
Mar 2019
-
$2.17 B(+56.3%)
$7.52 B(-1.1%)
Dec 2018
$7.56 B(+1.8%)
$1.39 B(-24.7%)
$7.60 B(-0.0%)
Sept 2018
-
$1.84 B(-13.2%)
$7.60 B(-0.8%)
June 2018
-
$2.12 B(-5.7%)
$7.67 B(+1.1%)
Mar 2018
-
$2.25 B(+62.1%)
$7.59 B(+3.9%)
Dec 2017
$7.42 B(+4.3%)
$1.39 B(-27.0%)
$7.30 B(-1.8%)
Sept 2017
-
$1.90 B(-6.8%)
$7.44 B(+0.6%)
June 2017
-
$2.04 B(+3.7%)
$7.40 B(+2.0%)
Mar 2017
-
$1.97 B(+29.1%)
$7.26 B(+2.1%)
Dec 2016
$7.11 B(+9.8%)
$1.53 B(-18.1%)
$7.11 B(+12.1%)
Sept 2016
-
$1.86 B(-1.8%)
$6.34 B(+1.2%)
June 2016
-
$1.90 B(+4.1%)
$6.26 B(+0.8%)
Mar 2016
-
$1.82 B(+140.8%)
$6.21 B(-4.9%)
Dec 2015
$6.48 B(+6.4%)
$757.28 M(-57.6%)
$6.53 B(-7.1%)
Sept 2015
-
$1.79 B(-3.4%)
$7.03 B(+3.0%)
June 2015
-
$1.85 B(-13.7%)
$6.83 B(+2.6%)
Mar 2015
-
$2.14 B(+70.4%)
$6.66 B(+9.2%)
Dec 2014
$6.09 B(+4.9%)
$1.26 B(-20.5%)
$6.10 B(-1.4%)
Sept 2014
-
$1.58 B(-5.7%)
$6.18 B(+1.4%)
June 2014
-
$1.68 B(+6.0%)
$6.10 B(+1.8%)
Mar 2014
-
$1.58 B(+17.8%)
$5.99 B(+3.2%)
Dec 2013
$5.80 B(+20.6%)
$1.34 B(-10.2%)
$5.80 B(+5.9%)
Sept 2013
-
$1.49 B(-4.7%)
$5.47 B(+3.3%)
June 2013
-
$1.57 B(+12.4%)
$5.30 B(+4.3%)
Mar 2013
-
$1.39 B(+36.8%)
$5.08 B(+5.4%)
Dec 2012
$4.81 B(+16.1%)
$1.02 B(-22.8%)
$4.82 B(+0.9%)
Sept 2012
-
$1.32 B(-2.0%)
$4.78 B(+5.0%)
June 2012
-
$1.35 B(+18.7%)
$4.55 B(+6.5%)
Mar 2012
-
$1.13 B(+16.0%)
$4.27 B(+3.0%)
Dec 2011
$4.15 B(+24.0%)
$977.58 M(-10.6%)
$4.15 B(+6.6%)
Sept 2011
-
$1.09 B(+2.4%)
$3.89 B(+5.5%)
June 2011
-
$1.07 B(+5.8%)
$3.69 B(+5.2%)
Mar 2011
-
$1.01 B(+40.1%)
$3.51 B(+5.1%)
Dec 2010
$3.34 B(+17.2%)
$720.73 M(-19.0%)
$3.33 B(+2.2%)
Sept 2010
-
$889.81 M(+0.5%)
$3.26 B(+5.0%)
June 2010
-
$885.45 M(+5.5%)
$3.11 B(+3.6%)
Mar 2010
-
$838.98 M(+29.1%)
$3.00 B(+5.4%)
Dec 2009
$2.85 B(+16.8%)
$649.87 M(-11.3%)
$2.85 B(+9.1%)
Sept 2009
-
$733.02 M(-5.6%)
$2.61 B(+0.5%)
June 2009
-
$776.79 M(+13.2%)
$2.59 B(+7.5%)
Mar 2009
-
$686.42 M(+66.8%)
$2.41 B(+1.5%)
Dec 2008
$2.44 B(+48.4%)
$411.63 M(-42.7%)
$2.38 B(+8.6%)
Sept 2008
-
$718.81 M(+20.5%)
$2.19 B(+11.4%)
June 2008
-
$596.69 M(-8.3%)
$1.97 B(+4.7%)
Mar 2008
-
$650.48 M(+190.8%)
$1.88 B(+14.8%)
Dec 2007
$1.65 B(+7.3%)
$223.68 M(-54.8%)
$1.64 B(-7.9%)
Sept 2007
-
$494.88 M(-2.7%)
$1.78 B(+4.0%)
June 2007
-
$508.61 M(+24.6%)
$1.71 B(+3.9%)
Mar 2007
-
$408.19 M(+12.2%)
$1.64 B(+6.7%)
Dec 2006
$1.54 B(+13.9%)
$363.90 M(-14.8%)
$1.54 B(+4.0%)
Sept 2006
-
$426.95 M(-3.8%)
$1.48 B(+3.5%)
June 2006
-
$443.88 M(+45.7%)
$1.43 B(+3.4%)
Mar 2006
-
$304.64 M(-0.2%)
$1.38 B(+2.8%)
Dec 2005
$1.35 B(+14.7%)
$305.28 M(-19.1%)
$1.35 B(-2.2%)
Sept 2005
-
$377.50 M(-4.8%)
$1.38 B(+7.1%)
June 2005
-
$396.48 M(+48.8%)
$1.29 B(+7.6%)
Mar 2005
-
$266.44 M(-20.6%)
$1.19 B(+1.1%)
Dec 2004
$1.18 B
$335.65 M(+17.2%)
$1.18 B(-258.8%)
Sept 2004
-
$286.45 M(-6.4%)
-$743.79 M(+327.1%)
DateAnnualQuarterlyTTM
June 2004
-
$305.95 M(+20.8%)
-$174.15 M(-148.5%)
Mar 2004
-
$253.37 M(-115.9%)
$358.96 M(-57.5%)
Dec 2003
$973.92 M(+28.1%)
-$1.59 B(-285.7%)
$844.54 M(+12.6%)
Sept 2003
-
$856.09 M(+2.0%)
$750.05 M(+0.3%)
June 2003
-
$839.06 M(+13.5%)
$747.75 M(+33.1%)
Mar 2003
-
$738.95 M(-143.9%)
$561.66 M(+5.4%)
Dec 2002
$760.15 M(+13.0%)
-$1.68 B(-297.2%)
$532.93 M(-35.0%)
Sept 2002
-
$853.80 M(+30.8%)
$820.23 M(+7.5%)
June 2002
-
$652.97 M(-8.1%)
$763.23 M(-2.5%)
Mar 2002
-
$710.22 M(-150.8%)
$782.93 M(+6.6%)
Dec 2001
$672.69 M(+27.9%)
-$1.40 B(-275.3%)
$734.28 M(+64.1%)
Sept 2001
-
$796.80 M(+18.5%)
$447.56 M(-70.4%)
June 2001
-
$672.68 M(+1.7%)
$1.51 B(-8.4%)
Mar 2001
-
$661.56 M(-139.3%)
$1.65 B(-4.4%)
Dec 2000
$525.93 M(+25.6%)
-$1.68 B(-190.4%)
$1.73 B(+3.2%)
Sept 2000
-
$1.86 B(+129.8%)
$1.67 B(+164.8%)
June 2000
-
$810.58 M(+9.9%)
$631.91 M(+18.0%)
Mar 2000
-
$737.25 M(-142.4%)
$535.67 M(+7.6%)
Dec 1999
$418.81 M(+95.5%)
-$1.74 B(-311.5%)
$497.68 M(+24.2%)
Sept 1999
-
$821.66 M(+15.0%)
$400.56 M(+21.5%)
June 1999
-
$714.35 M(+2.2%)
$329.62 M(+16.3%)
Mar 1999
-
$699.25 M(-138.1%)
$283.42 M(+49.8%)
Dec 1998
$214.19 M(-39.5%)
-$1.83 B(-344.4%)
$189.17 M(-64.5%)
Sept 1998
-
$750.72 M(+12.4%)
$533.53 M(+30.1%)
June 1998
-
$668.15 M(+10.4%)
$410.22 M(+9.7%)
Mar 1998
-
$605.00 M(-140.6%)
$373.83 M(+8.7%)
Dec 1997
$354.00 M(+3.6%)
-$1.49 B(-337.5%)
$343.90 M(-1.1%)
Sept 1997
-
$627.41 M(-0.7%)
$347.59 M(-2.2%)
June 1997
-
$631.76 M(+9.9%)
$355.50 M(+10.7%)
Mar 1997
-
$575.07 M(-138.7%)
$321.20 M(-8.5%)
Dec 1996
$341.54 M(+2.1%)
-$1.49 B(-334.0%)
$351.00 M(+13.0%)
Sept 1996
-
$635.32 M(+6.3%)
$310.67 M(+22.2%)
June 1996
-
$597.46 M(-1.2%)
$254.25 M(-17.8%)
Mar 1996
-
$604.87 M(-139.6%)
$309.26 M(+10.6%)
Dec 1995
$334.50 M(+15.3%)
-$1.53 B(-363.8%)
$279.55 M(-39.6%)
Sept 1995
-
$578.90 M(-11.3%)
$462.93 M(+7.2%)
June 1995
-
$652.47 M(+13.4%)
$431.98 M(+41.5%)
Mar 1995
-
$575.16 M(-142.8%)
$305.32 M(+57.9%)
Dec 1994
$290.00 M(-3.4%)
-$1.34 B(-345.2%)
$193.31 M(-61.2%)
Sept 1994
-
$547.95 M(+4.2%)
$498.12 M(+20.1%)
June 1994
-
$525.81 M(+13.5%)
$414.84 M(+11.2%)
Mar 1994
-
$463.15 M(-144.6%)
$373.05 M(+13.9%)
Dec 1993
$300.23 M(+56.1%)
-$1.04 B(-323.6%)
$327.44 M(+42.2%)
Sept 1993
-
$464.66 M(-4.0%)
$230.21 M(+4.7%)
June 1993
-
$484.02 M(+15.9%)
$219.90 M(+17.9%)
Mar 1993
-
$417.53 M(-136.8%)
$186.47 M(-3.2%)
Dec 1992
$192.36 M(-12.6%)
-$1.14 B(-350.0%)
$192.69 M(-58.0%)
Sept 1992
-
$454.35 M(+0.8%)
$458.91 M(+27.5%)
June 1992
-
$450.60 M(+6.3%)
$359.94 M(+45.3%)
Mar 1992
-
$423.75 M(-148.7%)
$247.65 M(+17.7%)
Dec 1991
$220.07 M(+29.1%)
-$869.78 M(-344.7%)
$210.43 M(-4.3%)
Sept 1991
-
$355.38 M(+5.1%)
$219.95 M(+10.7%)
June 1991
-
$338.30 M(-12.5%)
$198.62 M(+11.5%)
Mar 1991
-
$386.54 M(-144.9%)
$178.09 M(+99.9%)
Dec 1990
$170.48 M(+18.5%)
-$860.27 M(-357.5%)
$89.08 M(-72.2%)
Sept 1990
-
$334.06 M(+5.1%)
$320.60 M(+45.5%)
June 1990
-
$317.76 M(+6.8%)
$220.29 M(+61.6%)
Mar 1990
-
$297.53 M(-147.3%)
$136.35 M(+19.6%)
Dec 1989
$143.85 M(+3.2%)
-$628.74 M(-369.0%)
$113.96 M(-61.5%)
Sept 1989
-
$233.75 M(-0.0%)
$295.66 M(+19.7%)
June 1989
-
$233.82 M(-15.0%)
$247.03 M(+9.3%)
Mar 1989
-
$275.14 M(-161.5%)
$226.03 M(+66.2%)
Dec 1988
$139.39 M(+47.1%)
-$447.04 M(-341.5%)
$136.02 M(+8.2%)
Sept 1988
-
$185.12 M(-13.0%)
$125.67 M(+3.7%)
June 1988
-
$212.81 M(+15.0%)
$121.19 M(+51.2%)
Mar 1988
-
$185.13 M(-140.5%)
$80.13 M(+12.1%)
Dec 1987
$94.76 M(+14.3%)
-$457.39 M(-353.2%)
$71.49 M(-64.6%)
Sept 1987
-
$180.64 M(+5.2%)
$202.13 M(+34.0%)
June 1987
-
$171.75 M(-2.7%)
$150.89 M(+33.6%)
Mar 1987
-
$176.49 M(-154.0%)
$112.91 M(+105.3%)
Dec 1986
$82.91 M(+18.9%)
-$326.75 M(-352.5%)
$55.00 M(-56.7%)
Sept 1986
-
$129.40 M(-3.3%)
$126.97 M(+35.8%)
June 1986
-
$133.77 M(+12.8%)
$93.51 M(+70.1%)
Mar 1986
-
$118.58 M(-146.5%)
$54.98 M(+90.2%)
Dec 1985
$69.75 M(+26.2%)
-$254.79 M(-365.6%)
$28.90 M(-65.6%)
Sept 1985
-
$95.94 M(+0.7%)
$83.91 M(+5.5%)
June 1985
-
$95.24 M(+3.0%)
$79.51 M(+5.4%)
Mar 1985
-
$92.51 M(-146.3%)
$75.44 M(+0.5%)
Dec 1984
$55.29 M
-$199.77 M(-318.2%)
$75.07 M(-72.7%)
Sept 1984
-
$91.54 M(+0.4%)
$274.84 M(+49.9%)
June 1984
-
$91.16 M(-1.1%)
$183.30 M(+98.9%)
Mar 1984
-
$92.14 M
$92.14 M

FAQ

  • What is Novo Nordisk A/S annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual EBIT year-on-year change?
  • What is Novo Nordisk A/S quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly EBIT year-on-year change?
  • What is Novo Nordisk A/S TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Novo Nordisk A/S?
  • What is Novo Nordisk A/S TTM EBIT year-on-year change?

What is Novo Nordisk A/S annual earnings before interest & taxes?

The current annual EBIT of NVO is $15.28 B

What is the all time high annual EBIT for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual earnings before interest & taxes is $16.64 B

What is Novo Nordisk A/S annual EBIT year-on-year change?

Over the past year, NVO annual earnings before interest & taxes has changed by +$5.43 B (+55.18%)

What is Novo Nordisk A/S quarterly earnings before interest & taxes?

The current quarterly EBIT of NVO is $5.19 B

What is the all time high quarterly EBIT for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly earnings before interest & taxes is $5.19 B

What is Novo Nordisk A/S quarterly EBIT year-on-year change?

Over the past year, NVO quarterly earnings before interest & taxes has changed by +$773.47 M (+17.52%)

What is Novo Nordisk A/S TTM earnings before interest & taxes?

The current TTM EBIT of NVO is $17.70 B

What is the all time high TTM EBIT for Novo Nordisk A/S?

Novo Nordisk A/S all-time high TTM earnings before interest & taxes is $17.70 B

What is Novo Nordisk A/S TTM EBIT year-on-year change?

Over the past year, NVO TTM earnings before interest & taxes has changed by +$4.84 B (+37.58%)